RCUS Latest Headlines

Arcus Biosciences sets a November 16 London fireside chat at Jefferies Global Healthcare Conference

Market Chameleon (Tue, 3-Nov 9:20 AM)

Arcus Biosciences prices 14.29M-share offering at $17.50, with a 30-day option for 2.14M more

Market Chameleon (Thu, 22-Oct 7:36 AM)

Arcus highlights nearly three-year median overall survival signal for casdatifan in late-line kidney cancer

Market Chameleon (Tue, 20-Oct 10:26 AM)

Arcus spotlights ARC-20 kidney cancer data, including a 35-month median overall survival in late-line casdatifan monotherapy

Market Chameleon (Tue, 20-Oct 8:43 AM)